Cargando…
An Overview of Targeted Therapies in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is the most aggressive adult leukemia, characterized by clonal differentiation arrest of progenitor or precursor hematopoietic cells. Intense preclinical and clinical research has led to regulatory approval of several targeted therapeutics, administered either as single...
Autores principales: | Turkalj, Sven, Radtke, Felix A., Vyas, Paresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256410/ https://www.ncbi.nlm.nih.gov/pubmed/37304938 http://dx.doi.org/10.1097/HS9.0000000000000914 |
Ejemplares similares
-
A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cells
por: Turkalj, Sven, et al.
Publicado: (2023) -
New directions for emerging therapies in acute myeloid leukemia: the next chapter
por: Daver, Naval, et al.
Publicado: (2020) -
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions
por: Daver, Naval G., et al.
Publicado: (2022) -
Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023) -
Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)